Press release
Global Fibromyalgia Treatments (FM) Market Perceives Aggrandized Growth; MRFR Unleashes Industry Prognostications Up to 2022
Fibromyalgia, often abbreviated to FM is believed to have no cure and only its symptoms can be treated to make the condition manageable. FM Treatments accentuate on reducing pain, improving sleep by prescribing antidepressants coupled with the other treatments such as counselling, cognitive behaviour therapy (CBT), and exercise that benefits in reducing pain and relaxation techniques help reducing muscles tension. Over the last few years, thanks to the technological advancements, that has brought innovations in Fibromyalgia treatments, offering phenomenal relief and benefitting results and proving to be a boon to the patients by improving their quality of life. This has provided impetus to the market growth of Fibromyalgia Treatments.Get a sample report at https://www.marketresearchfuture.com/sample_request/1879 .
Accrediting the sedulous work of the key players, who brought novelties in FM treatments helping the FM market to gain increasing traction and grow widely, the Market Research Future, has recently published a meticulous study report, giving out the complete market prognosis up to 2022. According to which, the Global Fibromyalgia Treatments Market is expected to grow further continuing with the same trends over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value.
The Global Fibromyalgia Treatments Market is driven by some of the prominent players including A&S Pharmaceutical Corp, Leiner Health Products, Inc., LNK International, Inc., Pharmaceutical Formulations, Inc., Bayer Healthcare, Sanofi, Endo International, Johnson & Johnson, Purdue Pharma, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Pfizer Inc., and Merck & Co., Inc. Acknowledging, the sedulous work of these key players, MRFR profiles them in its market analysis.
Augmented prevalence rate of fibromyalgia is one of the prime factors that propel the market growth of Fibromyalgia Treatment market. The market is anticipated to progress massively in the near future. as many new treatments will emerge and treating the disease more effectively increasing success rates. There have been a significant numbers of technological advancements in the medical science which will result in fostering the growth of fibromyalgia treatment market globally. The increasing demand for fibromyalgia treatments in North American countries like US and Canada is anticipated to push the market growth of Fibromyalgia Treatment market to the ascended level.
On the other hand factors such as the unmet medical needs are likely to pose challenges to the growth of Fibromyalgia Treatment market. Adversely, growing technology in the healthcare industry plays a major role in the growth of this market as new techniques have been evolved for the treatment of fibromyalgia diseases which are growing effectively and efficiently, which makes the demand for Fibromyalgia Treatment grow eventually.
Browse Complete Report at https://www.marketresearchfuture.com/reports/fibromyalgia-treatments-market-1879 .
Fibromyalgia Treatments Global Market - Competitive Analysis
The global market of Fibromyalgia Treatments appears to be highly competitive with the presence of several well-established and small players. Well established players incorporate acquisition, collaboration, partnership, expansion, and technology launch in order to gain competitive advantage in this market. Top players are investing heavily in R&D and clinical trials to develop effective drugs to cure Fibromyalgia.
To help accelerating pharmaceutical innovations for patients and gain a better understanding of major diseases, these pharma companies collaborate with a number of partners from academia and the biotech industry who contribute specialized knowledge and cutting-edge technologies. These co-operations form one of the pillars of company’s innovation strategy. Through partnering, companies can leverage today’s scientific know-how and translate it into innovative medicines. True partnerships have the power to kindle the innovative impulses that advance medicine and benefit patients as well as partners.
Industry/Innovation/ Related News:
December 04, 2017 – Soterix Medical (Singapore) announced approval of Singapore’s Health Sciences Authority (HSA) for it’s non-invasive therapeutic device, PainX (as an alternative to treatment for fibromyalgia-related migraines and other chronic pain with medication) and Depression tDCS-LTE (medical device for symptoms associated with major depression) which is based on Soterix’s proprietary transcranial Direct Current Stimulation (tDCS) technology, in which a mild electrical current is delivered to the head through electrodes. A special cap ensures that patches are correctly positioned.
November 21, 2017 – Research team at Penticton (Canada) received funding/ grant of more than $91,000 from The Canadian Rheumatology Association for their efforts to treat Fibromyalgia patients struggling to deal with their pain. The funding also helps promote a local Medical Research Fund being established through the Community Foundation of the South Okanagan Similkameen.
November 1, 2017 – Avacen Medical (US) announced winning an innovation award for a dry heat device(Avacen 100) it invented to treat the pain that is widespread in fibromyalgia (Fibromyalgia Pain Control Device) by the global consulting firm Frost & Sullivan (CA, US) - European New Product Innovation Award for developing the Avacen 100. The consultant made the award after analyzing all of the fibromyalgia management devices that are available in Europe.
November 2017 – IQuity, a leading life science technology company in the field of RNA-based diagnosis, announced that the company is preparing to launch, before the end of this year, its third test ‘IsolateFibromyalgia’ to aid the diagnosis of fibromyalgia, a condition characterized by widespread pain alongside other symptoms.
November 21, 2017 – ViaDerma, Inc. (US) announced that it is granted approval to sell VitaStem(TM) its FDA Registered Topical Antibiotic on Amazon.com and expanding testing into major US hospital chains to ramp up domestic sales & begins. The Company would combine its proprietary solutions with CBD's and other natural products that treat psoriasis, fibromyalgia for pain and other ailments. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2018.
More Inquire at https://www.marketresearchfuture.com/enquiry/1879 .
Fibromyalgia Treatments Global Market - Regional Analysis
Globally North America is the largest market for fibromyalgia treatments. Europe is the second-largest market and Asia Pacific is expected to grow at a rapid rate. Whereas, Asia-Pacific is expected to be the fastest growing market during the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us
Market Research Future
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Fibromyalgia Treatments (FM) Market Perceives Aggrandized Growth; MRFR Unleashes Industry Prognostications Up to 2022 here
News-ID: 931568 • Views: …
More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034).
The global small boat industry is witnessing significant growth, driven…

Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034).
The automotive industry is witnessing a significant transformation in vehicle…

Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035).
With the global automotive industry focused on precision,…

Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034).
Valet parking technology is emerging as a transformative…
More Releases for Fibromyalgia
Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalg …
The Fibromyalgia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Fibromyalgia Treatment Market?
The market for the treatment of fibromyalgia has been expanding consistently in past years. At a compound annual growth rate (CAGR) of 3.9%, it is…
SN Clinic's Effective Treatment of Fibromyalgia Symptoms
Image: https://www.globalnewslines.com/uploads/2025/02/1740408683.jpg
SN Clinic Logo
Fibromyalgia can be a debilitating condition, but SN Clinic offers hope through innovative treatments like MLS Laser Therapy and complementary massage therapies. By addressing chronic pain through a holistic approach, patients can experience significant relief and an improved quality of life.
What is Fibromyalgia and What Does Current Data Say?
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Affecting…
Prominent Fibromyalgia Treatment Market Trend for 2025: Market Leaders Focus On …
What Are the Projected Growth and Market Size Trends for the Fibromyalgia Treatment Market?
The Fibromyalgia Treatment market is expected to grow from $2.79 billion in 2024 to $2.9 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing prevalence of fibromyalgia, greater awareness about the condition, government initiatives, and rising disposable incomes.
The fibromyalgia treatment market is projected to see steady growth, reaching $3.45 billion by…
Advancements in Fibromyalgia Treatments Driving Market Expansion
The fibromyalgia treatment market is experiencing a steady upward trajectory, with significant growth expected over the next decade. Estimated at USD 2.77 billion in 2023, the market is projected to reach approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. This expansion is driven by several key factors, including advances in treatment options, increasing demand for effective therapies, and…
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues.
Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD.
To know more about Fibromyalgia - Drug Pipeline, visit - https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/
Fibromyalgia…
Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required…